NCT03085043 2026-03-05
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
Clinical Trials
33 trialsNCT07276438 2026-02-05
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
Jonsson Comprehensive Cancer Center
Phase NA Recruiting
NCT06788886 2025-12-30
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Mayo Clinic
Phase NA Recruiting
NCT06995053 2025-11-10
ILLUSION
Jonsson Comprehensive Cancer Center
Phase NA Recruiting
NCT06389786 2025-10-24
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
Mayo Clinic
Phase NA Recruiting
NCT06325046 2025-10-16
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Mayo Clinic
Phase NA Recruiting
NCT05055843 2025-10-14
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05710380 2025-10-01
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
University of Chicago
Phase NA Recruiting
NCT06580015 2025-07-18
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer
City of Hope Medical Center
Phase NA Recruiting
NCT05830838 2025-05-21
DAPPER
Mayo Clinic
Phase NA Active not recruiting
NCT02989623 2025-04-24
Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA
Thomas Jefferson University
Phase NA Completed
NCT01653093 2025-04-11
3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer
University of Cincinnati
Phase NA Active not recruiting
NCT02722525 2025-03-04
Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Active not recruiting
NCT00002981 2024-06-03
PET Scan in Treating Patients With Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01812668 2021-08-05
Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT02121600 2019-05-07
18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Terminated
NCT02939456 2019-03-14
DIRMP
University Hospitals of North Midlands NHS Trust
Phase NA Completed
NCT00588679 2019-03-08
Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02831920 2019-01-17
CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Unknown
NCT01878773 2017-08-22
Prostate Delineation: High Quality Volume CT
University Health Network, Toronto
Phase NA Completed
NCT01412853 2017-06-21
ERIS
Centre Georges Francois Leclerc
Phase NA Completed
NCT01993160 2017-01-13
18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
University Health Network, Toronto
Phase NA Completed
NCT01878058 2016-11-01
Identifying Prostate Brachytherapy Seeds Using MRI
University Health Network, Toronto
Phase NA Completed
NCT01761812 2016-10-18
Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods
Sunnybrook Health Sciences Centre
Phase NA Terminated
NCT02169063 2016-08-31
Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer
University of Washington
Phase NA Withdrawn
NCT00310479 2016-02-25
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
AHS Cancer Control Alberta
Phase NA Completed
NCT00429338 2015-01-09
3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate
M.D. Anderson Cancer Center
Phase NA Terminated
NCT01764347 2014-01-28
Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate Cancer
University of Southern California
Phase NA Completed
NCT00967954 2014-01-10
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00796874 2013-07-25
Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance
Roswell Park Cancer Institute
Phase NA Withdrawn
NCT00147238 2012-08-07
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00032058 2011-02-21
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase NA Completed
NCT00165386 2009-12-09
MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients
Dana-Farber Cancer Institute
Phase NA Completed